Raloxifene treatment in Maternal Immune Activation model of Schizophrenia


Studying the molecular basis of raloxifene (a SERM) modulation of dopamine signalling in schizophrenia, which uses a maternal immune activation rodent model of schizophrenia to better understand how raloxifene brings about its effects.


Health Areas

Expertise & facilities